Product
Supplier
Encyclopedia
Inquiry
CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality | buy - large image1
CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality | buy - image1

CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality |

Unit Price:

$100/G FOB

Get Latest Price
Grade:

Pharmaceutical Grade

Content:

99%

Port:

香港

Packaging:

20mg*10vials

Price valid (until):

2027-03-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

PEPTIDES

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    WhatsApp: +86 1507618 9566

    Shop CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality |-Detailed Image 1



    Shop CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality |-Detailed Image 2


    Shop CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality |-Detailed Image 3
    Shop CH20 | Premium Research-Grade Beauty Peptide| 99% Purity | Lyophilized Powder | High Quality |-Detailed Image 4

    is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Basic Info
    Product Name:

    CH20 | Premium Research-Grade Beauty Peptide |Chonluten| 99% Purity | Lyophilized Powder | High Quality | Retatrutide, Tirzepatide, Klow

    Categories:

    Polypeptide

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    PEPTIDES

    Location:

    Room 305, 3rd Floor, Unit 2, Building 48, Datangxia Zone 2, Choucheng Subdistrict, Yiwu, Jinhua, Zhejiang Province, China

    Year of Establishment:

    2026

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.